U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Typical absence seizure

MedGen UID:
1790454
Concept ID:
C5551411
Disease or Syndrome
Synonyms: Typical absence; Typical absence seizures
SNOMED CT: Typical absence seizure (1173024006)
 
HPO: HP:0011147

Definition

A typical absence seizure is a type of generalized non-motor (absence) seizure characterized by its sudden onset, interruption of ongoing activities, a blank stare, possibly a brief upward deviation of the eyes. Usually the patient will be unresponsive when spoken to. Duration is a few seconds to half a minute with very rapid recovery. Although not always available, an EEG would usually show 3 Hz generalized epileptiform discharges during the event. [from HPO]

Term Hierarchy

Conditions with this feature

Episodic ataxia type 5
MedGen UID:
356142
Concept ID:
C1866039
Disease or Syndrome
An extremely rare form of hereditary episodic ataxia with characteristics of recurrent episodes of vertigo and ataxia lasting several hours.
Epilepsy, idiopathic generalized, susceptibility to, 9
MedGen UID:
413424
Concept ID:
C2750887
Finding
For a general phenotypic description and a discussion of genetic heterogeneity of idiopathic generalized epilepsy, see 600669. Juvenile myoclonic epilepsy is a subtype of idiopathic generalized epilepsy; see 254770 for a general phenotypic description and a discussion of genetic heterogeneity of JME.
ADNP-related multiple congenital anomalies - intellectual disability - autism spectrum disorder
MedGen UID:
862975
Concept ID:
C4014538
Disease or Syndrome
ADNP-related disorder is characterized by hypotonia, severe speech and motor delay, mild-to-severe intellectual disability, and characteristic facial features (prominent forehead, high anterior hairline, wide and depressed nasal bridge, and short nose with full, upturned nasal tip) based on a cohort of 78 individuals. Features of autism spectrum disorder are common (stereotypic behavior, impaired social interaction). Other common findings include additional behavioral problems, sleep disturbance, brain abnormalities, seizures, feeding issues, gastrointestinal problems, visual dysfunction (hypermetropia, strabismus, cortical visual impairment), musculoskeletal anomalies, endocrine issues including short stature and hormonal deficiencies, cardiac and urinary tract anomalies, and hearing loss.
Developmental and epileptic encephalopathy, 33
MedGen UID:
897930
Concept ID:
C4225337
Disease or Syndrome
Developmental and epileptic encephalopathy-33 (DEE33) is a neurologic disorder characterized by the onset of various types of seizures in the first months of life. Affected individuals show severe global developmental delay with impaired intellectual development and poor or absent speech (summary by de Ligt et al., 2012). For a general phenotypic description and a discussion of genetic heterogeneity of DEE, see 308350.
Short stature-brachydactyly-obesity-global developmental delay syndrome
MedGen UID:
934656
Concept ID:
C4310689
Disease or Syndrome
A rare genetic, multiple congenital anomalies syndrome characterized by short stature, hand brachydactyly with hypoplastic distal phalanges, global development delay, intellectual disability, and more variably seizures, obesity, and craniofacial dysmorphism that includes microcephaly, high forehead, flat face, hypertelorism, deep set eyes, flat nasal bridge, averted nostrils, long philtrum, thin lip vermilion, and short neck.
Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome
MedGen UID:
1675672
Concept ID:
C5193040
Disease or Syndrome
Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome is an autosomal recessive disorder with a highly variable phenotype. Although all patients have polymicrogyria and other variable structural brain anomalies on imaging, only some show developmental delay and/or seizures. Similarly, only some patients have connective tissue defects that particularly affect the vascular system and can result in early death (summary by Vandervore et al., 2017).
Developmental and epileptic encephalopathy, 74
MedGen UID:
1680535
Concept ID:
C5193074
Disease or Syndrome
Developmental and epileptic encephalopathy-74 (DEE74) is neurologic disorder characterized by the onset of refractory seizures in the first months of life. Seizure types are variable and include infantile spasms, myoclonic, tonic, atonic, and absence, often with secondary generalization. Affected individuals have severe global developmental delay with hypotonia, severe motor impairment, roving eye movements, and absent language (summary by Shen et al., 2017). For a general phenotypic description and a discussion of genetic heterogeneity of DEE, see 308350.
Developmental and epileptic encephalopathy 100
MedGen UID:
1809351
Concept ID:
C5676932
Disease or Syndrome
Developmental and epileptic encephalopathy-100 (DEE100) is a severe neurologic disorder characterized by global developmental delay and onset of variable types of seizures in the first months or years of life. Most patients have refractory seizures and show developmental regression after seizure onset. Affected individuals have ataxic gait or inability to walk and severe to profoundly impaired intellectual development, often with absent speech. Additional more variable features may include axial hypotonia, hyperkinetic movements, dysmorphic facial features, and brain imaging abnormalities (summary by Schneider et al., 2021). For a general phenotypic description and a discussion of genetic heterogeneity of DEE, see 308350.
Developmental and epileptic encephalopathy 109
MedGen UID:
1824036
Concept ID:
C5774263
Disease or Syndrome
Developmental and epileptic encephalopathy-109 (DEE109) is characterized by the onset of various types of seizures in the first months or years of life. Affected individuals show developmental delay before and concurrent with the onset of seizures. Features include impaired intellectual development with poor speech, ataxic gait, coordination problems, and behavioral abnormalities (Manivannan et al., 2022). For a general phenotypic description and a discussion of genetic heterogeneity of DEE, see 308350.

Professional guidelines

PubMed

Wirrell EC, Hood V, Knupp KG, Meskis MA, Nabbout R, Scheffer IE, Wilmshurst J, Sullivan J
Epilepsia 2022 Jul;63(7):1761-1777. Epub 2022 May 12 doi: 10.1111/epi.17274. PMID: 35490361Free PMC Article
Laino D, Mencaroni E, Esposito S
Int J Environ Res Public Health 2018 Oct 12;15(10) doi: 10.3390/ijerph15102232. PMID: 30321985Free PMC Article
Espay AJ, Aybek S, Carson A, Edwards MJ, Goldstein LH, Hallett M, LaFaver K, LaFrance WC Jr, Lang AE, Nicholson T, Nielsen G, Reuber M, Voon V, Stone J, Morgante F
JAMA Neurol 2018 Sep 1;75(9):1132-1141. doi: 10.1001/jamaneurol.2018.1264. PMID: 29868890Free PMC Article

Recent clinical studies

Etiology

Ikemoto S, Hamano SI, Yokota S, Koichihara R, Hirata Y, Matsuura R
Clin Neurophysiol 2020 Jun;131(6):1204-1209. Epub 2020 Mar 19 doi: 10.1016/j.clinph.2020.02.024. PMID: 32299003
Nasser H, Lopez-Hernandez E, Ilea A, Le Morvan N, Bellavoine V, Delanoë C, Auvin S
Epileptic Disord 2017 Jun 1;19(2):137-146. doi: 10.1684/epd.2017.0905. PMID: 28540848

Diagnosis

Vlachou M, Skrimpas GA, Kural MA, Rackauskaite G, Nikanorova N, Christensen J, Nikanorova M, Beniczky S
Epileptic Disord 2022 Apr 1;24(2):315-322. doi: 10.1684/epd.2021.1392. PMID: 34859792
San-Juan D, Mayorga AP, Anschel DJ, Avellán AM, González-Aragón MF, Cole AJ
Epilepsy Behav 2011 Jul;21(3):318-20. Epub 2011 May 14 doi: 10.1016/j.yebeh.2011.04.010. PMID: 21571594

Therapy

Vlachou M, Skrimpas GA, Kural MA, Rackauskaite G, Nikanorova N, Christensen J, Nikanorova M, Beniczky S
Epileptic Disord 2022 Apr 1;24(2):315-322. doi: 10.1684/epd.2021.1392. PMID: 34859792
Brigo F, Lattanzi S, Giussani G, Tassi L, Pietrafusa N, Galimberti CA, Nardone R, Bragazzi NL, Mecarelli O
Epilepsy Behav 2018 Apr;81:119-122. Epub 2018 Feb 14 doi: 10.1016/j.yebeh.2018.01.037. PMID: 29454607

Prognosis

Vlachou M, Skrimpas GA, Kural MA, Rackauskaite G, Nikanorova N, Christensen J, Nikanorova M, Beniczky S
Epileptic Disord 2022 Apr 1;24(2):315-322. doi: 10.1684/epd.2021.1392. PMID: 34859792
Nasser H, Lopez-Hernandez E, Ilea A, Le Morvan N, Bellavoine V, Delanoë C, Auvin S
Epileptic Disord 2017 Jun 1;19(2):137-146. doi: 10.1684/epd.2017.0905. PMID: 28540848
San-Juan D, Mayorga AP, Anschel DJ, Avellán AM, González-Aragón MF, Cole AJ
Epilepsy Behav 2011 Jul;21(3):318-20. Epub 2011 May 14 doi: 10.1016/j.yebeh.2011.04.010. PMID: 21571594

Clinical prediction guides

Vlachou M, Skrimpas GA, Kural MA, Rackauskaite G, Nikanorova N, Christensen J, Nikanorova M, Beniczky S
Epileptic Disord 2022 Apr 1;24(2):315-322. doi: 10.1684/epd.2021.1392. PMID: 34859792
Nasser H, Lopez-Hernandez E, Ilea A, Le Morvan N, Bellavoine V, Delanoë C, Auvin S
Epileptic Disord 2017 Jun 1;19(2):137-146. doi: 10.1684/epd.2017.0905. PMID: 28540848
Chen M, Guo D, Wang T, Jing W, Xia Y, Xu P, Luo C, Valdes-Sosa PA, Yao D
PLoS Comput Biol 2014 Mar;10(3):e1003495. Epub 2014 Mar 13 doi: 10.1371/journal.pcbi.1003495. PMID: 24626189Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...